Contact
Please use this form to send email to PR contact of this press release:
RBI Granted 'Fast Track' Designation by FDA, Validating Its Direct-to-Brain Stem Cell Therapy for Alzheimer's Disease
TO:
Robert Lynn
Regeneration Biomedical, Inc.
+1 877-240-1660